These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
653 related items for PubMed ID: 19464632
1. Molecular advances of brain tumors in radiation oncology. Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A. Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632 [Abstract] [Full Text] [Related]
4. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. Reardon DA, Wen PY. Oncologist; 2006 Feb 01; 11(2):152-64. PubMed ID: 16476836 [Abstract] [Full Text] [Related]
5. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Minniti G, Muni R, Lanzetta G, Marchetti P, Enrici RM. Anticancer Res; 2009 Dec 01; 29(12):5171-84. PubMed ID: 20044633 [Abstract] [Full Text] [Related]
6. Therapeutic strategies for inhibiting invasion in glioblastoma. Drappatz J, Norden AD, Wen PY. Expert Rev Neurother; 2009 Apr 01; 9(4):519-34. PubMed ID: 19344303 [Abstract] [Full Text] [Related]
7. Molecularly targeted therapies for malignant gliomas: advances and challenges. Penas-Prado M, Gilbert MR. Expert Rev Anticancer Ther; 2007 May 01; 7(5):641-61. PubMed ID: 17492929 [Abstract] [Full Text] [Related]
8. Therapeutic targeting of EGFR in malignant gliomas. Ye F, Gao Q, Cai MJ. Expert Opin Ther Targets; 2010 Mar 01; 14(3):303-16. PubMed ID: 20148717 [Abstract] [Full Text] [Related]
11. Glioblastoma multiforme: the role of DSB repair between genotype and phenotype. Fischer U, Meese E. Oncogene; 2007 Dec 10; 26(56):7809-15. PubMed ID: 18066094 [Abstract] [Full Text] [Related]
12. Recent advances in therapy for glioblastoma. Clarke J, Butowski N, Chang S. Arch Neurol; 2010 Mar 10; 67(3):279-83. PubMed ID: 20212224 [Abstract] [Full Text] [Related]
17. Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments. Kesari S. Semin Oncol; 2011 Dec 10; 38 Suppl 4():S2-10. PubMed ID: 22078644 [Abstract] [Full Text] [Related]
18. Hypericin uptake: a prognostic marker for survival in high-grade glioma. Ritz R, Müller M, Dietz K, Duffner F, Bornemann A, Roser F, Tatagiba M. J Clin Neurosci; 2008 Jul 10; 15(7):778-83. PubMed ID: 18394904 [Abstract] [Full Text] [Related]
19. Designer therapies for glioblastoma multiforme. Sathornsumetee S, Rich JN. Ann N Y Acad Sci; 2008 Oct 10; 1142():108-32. PubMed ID: 18990124 [Abstract] [Full Text] [Related]
20. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC. Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461 [Abstract] [Full Text] [Related] Page: [Next] [New Search]